Additional file 1 of Prenatal exposure to maternal asthma and asthma medication and neurodevelopmental outcomes: a population cohort study of 179,024 children
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Additional file 1. Supplementary Fig. 1 and Supplementary Tables 1–8. Supplementary Fig. 1: Directed acyclic graph (DAG) of confounder and mediator variables in the relationship between maternal asthma and child outcomes. Supplementary Table 1: Read codes for asthma diagnosis. Supplementary Table 2: Read codes for asthma medication. Supplementary Table 3: Medication groups. Supplementary Table 4: Read codes for ADHD diagnosis. Supplementary Table 5: Read codes for ADHD medications. Supplementary Table 6: Characteristics and outcomes of cohort participants by presence or absence of maternal asthma. Supplementary Table 7: Associations between treated and untreated maternal asthma and childhood outcomes. Supplementary Table 8: Associations between different combinations of classes of asthma medications and childhood outcomes.
Fields of Study & Subjects
Pregnancy and Medication Impact
Asthma and respiratory diseases
Prenatal Substance Exposure Effects
Publication details
- Journal / source
- Figshare
- Publication date
- 20 February 2026
- Language
- EN